Casper Marc N's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Dec 4, 2024
- Accession no.
- 0001127602-24-028621
- Filed
- Dec 4, 2024
- Trade date
- Dec 2-3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions and 0 derivative transactions. Open-market sales total $10.6M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casper Marc NCIK 0001216055 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Common Stock | SSaleDisposed | −500 | $528.02 | −$264,010 | 120,691.54 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −2,424 | $529.32 | −$1,283,071.68 | 118,267.54 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −4,917 | $530.05 | −$2,606,255.85 | 113,350.54 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −759 | $530.91 | −$402,960.69 | 112,591.54 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −400 | $531.77 | −$212,708 | 112,191.54 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −600 | $533.17 | −$319,902 | 111,591.54 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −400 | $534.24 | −$213,696 | 111,191.54 | Direct | |
| Dec 3, 2024 | Common Stock | SSaleDisposed | −400 | $528.67 | −$211,468 | 110,791.54 | Direct | |
| Dec 3, 2024 | Common Stock | SSaleDisposed | −400 | $529.53 | −$211,812 | 110,391.54 | Direct | |
| Dec 3, 2024 | Common Stock | SSaleDisposed | −1,345 | $530.88 | −$714,033.6 | 109,046.54 | Direct | |
| Dec 3, 2024 | Common Stock | SSaleDisposed | −3,352 | $532.04 | −$1,783,398.08 | 105,694.54 | Direct | |
| Dec 3, 2024 | Common Stock | SSaleDisposed | −3,448 | $533.04 | −$1,837,921.92 | 102,246.54 | Direct | |
| Dec 3, 2024 | Common Stock | SSaleDisposed | −1,050 | $533.95 | −$560,647.5 | 101,196.54 | Direct | |
| Dec 3, 2024 | Common Stock | SSaleDisposed | −5 | $534.71 | −$2,673.55 | 101,191.54 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.